Dallas Based Entrepreneurs Launch Medical Hologram B+A and Marketing Assistant Serving the Aesthetic Community

DALLAS, May 29, 2019 /PRNewswire/ — Aestheia Imaging, a hologram content management, and advertising subscription company introduced its disruptive technology at the American Society for Aesthetic Plastic Surgery last week at The Aesthetic Meeting in New Orleans. The company breaks the mold of in-practice marketing with the unveiling of XTHEIA; an interactive hologram display toting a Virtual Consult Assistant for medical office waiting rooms.  Aestheia’s launch poses a resolution to poor patient awareness; an underserved focal point of product education in the aesthetics industry.  

The company is led by Austin JM Podowski, CEO and accomplished Dallas Healthcare Business Tech executives Mike McDonald, President and Paul Herchman, Advisory Board Member. Well known Plastic Surgeon and photographer Dr. Barry DiBernardo of New Jersey Plastic Surgery leads the companies Medical Advisory Board and will continue to work to enhance upon the application. The company offers a connected holographic media platform to story map the patient journey to brand and product education. Through the research and development of Aestheia’s Medical Advisory Group, the company will offer holographic before and afters to patients so they can see pre-operative and post-operative procedure outcomes in true 3D, not previously available in the space.

“We are dedicated to providing novel and ground breaking product innovation for the entire Aesthetic Community,” comments McDonald. The company today offers a fully-automated and comprehensive holographic playlist for physician waiting rooms tethered to a cloud-based solution developed by the management team.

“We are changing the way medical companies and physicians communicate with their customers and patients.  The ALEXA of Aesthetics is now in the room,” states Podowski. The team has also designed a customer facing iPad Pro application that allows a physician to remote control the device offering an in-app camera for patient photos. Mr. Podowski later comments, “The response received at ASAPS The Aesthetic Meeting affirms that our vision and product meet a need and resuscitate a lost connection with the consumer.”

The management team is dedicated to further pioneering advancements in hologram, AI, and AR in the evolving medical practice of the 21st century.  The company is finalizing a third-round capital raise and will begin placement of their technology throughout Plastic Surgery Offices in North America in July 2019. The technology will also be on display in direct to consumer retail kiosks throughout the United States later this year. To get a sneak peak of Aestheia, follow the team’s development, or learn more about the technology, follow @aestheiaimaging or visit www.aestheiaimaging.com.

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/dallas-based-entrepreneurs-launch-medical-hologram-ba-and-marketing-assistant-serving-the-aesthetic-community-300857844.html

SOURCE Aestheia Imaging

Staff

Recent Posts

Genflow Biosciences PLC Announces Publication of a Key European Patent

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION…

3 hours ago

HeartBeam Reports Fourth Quarter and Full Year 2023 Financial Results

First Patients Enrolled in Pivotal Study Evaluating AIMIGo™ System for Synthesizing a 12-Lead ECG Ongoing…

12 hours ago

Delivra Health Brands Announces Adoption of a New Fixed Share Option Plan

Vancouver, British Columbia--(Newsfile Corp. - March 20, 2024) - Delivra Health Brands Inc. (TSXV: DHB)…

12 hours ago

Avinger Reports Fourth Quarter and Full Year 2023 Results

New Strategic Partnership Provides Funding to Support U.S. Growth Initiatives and Coronary Product Development, Opens…

12 hours ago

Music’s Healing Influence on Our Physiology

Pioneering the Path of Sound Therapy with Biofield TuningBURLINGTON, VERMONT / ACCESSWIRE / March 20,…

15 hours ago

NLS Pharmaceutics Announces $1.75 Million Registered Direct Offering

ZURICH, SWITZERLAND / ACCESSWIRE / March 20, 2024 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP)(Nasdaq:NLSPW) ("NLS" or…

15 hours ago